All Stories

  1. Lead replacement due to non-infectious reasons in patients undergoing traditional cardiac resynchronization therapy in long-term follow-up

    Article • November 2025, Cold Spring Harbor Laboratory Press

    Dr Radoslaw Lenarczyk

  2. Quality of life in patients with a leadless pacemaker versus transvenous pacemaker

    Article • Kardiologia Polska, October 2025, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  3. Echocardiographic imaging in patients with conduction system pacing

    Article • Cardiovascular Ultrasound, May 2025, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  4. Right atrial and dual chamber leadless pacemaker implantation: A pioneer experience in Poland. Findings from a multicentre national registry — a preliminary report

    Article • Kardiologia Polska, April 2025, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  5. Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, March 2025, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  6. The impact of shock therapy on depression development and remote prognosis in cardiac resynchronization therapy recipients

    Article • Cardiology Journal, February 2025, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  7. Left bundle branch area pacing in children: case series

    Article • European Heart Journal - Case Reports, January 2025, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  8. Long-term outcome, mortality predictors and cardiac-device related infective endocarditis in patients with surgically corrected valvular versus non-valvular heart failure treated with cardiac resynchronization therapy

    Article • Kardiologia Polska, November 2024, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  9. Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures

    Article • Nature Reviews Cardiology, October 2024, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  10. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  11. Single-chamber leadless pacemaker Aveir VR implantation: Pioneer experience in Poland. Insights and preliminary report from a multicenter national registry

    Article • Kardiologia Polska, August 2024, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  12. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-...

    Article • EP Europace, March 2024, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  13. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure

    Article • Kardiologia Polska, October 2023, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  14. Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments

    Article • Current Problems in Cardiology, August 2023, Elsevier

    Dr Radoslaw Lenarczyk

  15. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives

    Article • Advances in Clinical and Experimental Medicine, March 2023, Wroclaw Medical University

    Dr Radoslaw Lenarczyk

  16. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

    Article • EP Europace, December 2022, Oxford University Press (OUP)

    Prof. Francisco Marin , Dr Radoslaw Lenarczyk

  17. Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP‐AF general long‐term registry

    Article • ESC Heart Failure, November 2022, Wiley

    Dr Radoslaw Lenarczyk

  18. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry

    Article • European Journal of Internal Medicine, November 2022, Elsevier

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  19. Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey

    Article • EP Europace, October 2022, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  20. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    Article • BMC Medicine, September 2022, Springer Science + Business Media

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  21. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

    Article • European Heart Journal, August 2022, Oxford University Press (OUP)

    Professor Jolanta M Siller-Matula, Prof HECTOR BUENO, Dr Radoslaw Lenarczyk

  22. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

    Article • Age and Ageing, August 2022, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  23. Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS

    Article • EP Europace, August 2022, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  24. Quality of life in patients with a subcutaneous vs. transvenous implantable cardioverter-defibrillator

    Article • Kardiologia Polska, June 2022, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  25. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke

    Article • European Heart Journal, May 2022, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  26. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices

    Article • EP Europace, April 2022, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  27. Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries

    Article • International Journal of Environmental Research and Public Health, July 2021, MDPI AG

    Dr Radoslaw Lenarczyk

  28. Importance of Dedicated Units for the Management of Patients With Inherited Arrhythmia Syndromes

    Article • Circulation Genomic and Precision Medicine, April 2021, Wolters Kluwer Health

    Dr Radoslaw Lenarczyk

  29. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes

    Article • EP Europace, November 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  30. Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey

    Article • EP Europace, November 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  31. Patient perspective and safety of remote monitoring of implantable cardioverter-defibrillators in the Polish Nationwide Multicenter Registry: the Medtronic CareLink network evaluation

    Article • Kardiologia Polska, November 2020, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  32. Diagnosis, family screening, and treatment of inherited arrhythmogenic diseases in Europe: results of the European Heart Rhythm Association Survey

    Article • EP Europace, October 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  33. Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP‐AF General Long‐Term Registry

    Article • International Journal of Clinical Practice, September 2020, Wiley

    Dr Radoslaw Lenarczyk

  34. Quality indicators for the care and outcomes of adults with atrial fibrillation

    Article • EP Europace, August 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  35. Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review

    Article • EP Europace, August 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  36. Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2020, Oxford University Press (OUP)

    Nika Kuridze, Dr Radoslaw Lenarczyk

  37. Successful implantation of leadless pacemakers in children: a case series

    Article • European Heart Journal - Case Reports, March 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  38. Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot Survey

    Article • EP Europace, February 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  39. Trends in antithrombotic management in patients with atrial fibrillation: a report from Polish participants in the EURObservational Research Programme – Atrial Fibrillation General Long-Term Registry

    Article • Polish Archives of Internal Medicine, January 2020, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Radoslaw Lenarczyk

  40. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based...

    Article • EP Europace, January 2020, Oxford University Press (OUP)

    Assistant Professor Tatjana S Potpara, Dr Radoslaw Lenarczyk

  41. Factors influencing the use of leadless or transvenous pacemakers: results of the European Heart Rhythm Association Prospective Survey

    Article • EP Europace, January 2020, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  42. Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey

    Article • EP Europace, September 2019, Oxford University Press (OUP)

    Prof. Francisco Marin , Dr Radoslaw Lenarczyk

  43. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update

    Article • EP Europace, August 2019, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  44. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey

    Article • EP Europace, March 2019, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  45. The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association

    Article • Aging Clinical and Experimental Research, December 2018, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  46. Prevention of sudden cardiac death by the implantable cardioverter-defibrillator

    Article • Polish Archives of Internal Medicine, December 2018, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Radoslaw Lenarczyk

  47. Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction

    Article • Coronary Artery Disease, December 2018, Wolters Kluwer Health

    Dr Radoslaw Lenarczyk

  48. Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey

    Article • Kardiologia Polska, August 2018, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  49. Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective endocarditis

    Article • Kardiologia Polska, August 2018, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  50. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), C...

    Article • EP Europace, June 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  51. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey

    Article • EP Europace, June 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk, Prof. Francisco Marin

  52. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey

    Article • EP Europace, June 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  53. Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization

    Article • IJC Heart & Vasculature, June 2018, Elsevier

    Dr Radoslaw Lenarczyk

  54. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantati...

    Article • EP Europace, May 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  55. Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, April 2018, Elsevier

    Dr Radoslaw Lenarczyk

  56. Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices

    Article • Kardiologia Polska, March 2018, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  57. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey

    Article • EP Europace, February 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  58. Ventricular fibrillation induced by a radiofrequency energy delivery for premature ventricular contractions arising from the right ventricular outflow tract – is ICD indicated?

    Article • Polish Archives of Internal Medicine, January 2018, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Radoslaw Lenarczyk

  59. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey

    Article • EP Europace, January 2018, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  60. Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients

    Article • Archives of Medical Science, January 2018, Termedia Sp. z.o.o.

    Dr Radoslaw Lenarczyk

  61. Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association

    Article • EP Europace, December 2017, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  62. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey

    Article • EP Europace, November 2017, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  63. Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators

    Article • Journal of Interventional Cardiac Electrophysiology, October 2017, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  64. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey

    Article • EP Europace, August 2017, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  65. Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction

    Article • The American Journal of Cardiology, August 2017, Elsevier

    Dr Radoslaw Lenarczyk

  66. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians

    Article • Advances in Therapy, July 2017, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  67. The Changing Landscape for Stroke Prevention in AF

    Article • Journal of the American College of Cardiology, February 2017, Elsevier

    Professor Catarina Fonseca, Dr Radoslaw Lenarczyk, M.D Ph.D Serge Timsit, Mr JOSE A. CALVO-MANZANO, Prof. Francisco Marin

  68. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey

    Article • EP Europace, January 2017, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  69. Device-related infective endocarditis in cardiac resynchronization therapy recipients — Single center registry with over 2500 person-years follow up

    Article • International Journal of Cardiology, January 2017, Elsevier

    Dr Radoslaw Lenarczyk

  70. Gender-related differences in long-term outcome among high-risk patients with myocardial infarction treated invasively

    Article • Advances in Interventional Cardiology, January 2017, Termedia Sp. z.o.o.

    Dr Radoslaw Lenarczyk

  71. The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients

    Article • Cardiology, January 2017, Karger Publishers

    Dr Radoslaw Lenarczyk

  72. Ultra-fast, high-density 3D mapping system for catheter ablation of infrequent, “unmappable” idiopathic ventricular arrhythmia – a case report.

    Article • Heart Beat Journal, December 2016, Fundacja Heart Beat

    Dr Radoslaw Lenarczyk

  73. Automatyczny kardiowerter-defibrylator u chorych z nieischemiczną niewydolnością serca – czy wyniki badania Danish Trial są szokiem?

    Article • In a Good Rhythm, November 2016, Index Copernicus

    Dr Radoslaw Lenarczyk

  74. Do we need to monitor the percentage of biventricular pacing day by day?

    Article • International Journal of Cardiology, October 2016, Elsevier

    Dr Radoslaw Lenarczyk

  75. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey

    Article • EP Europace, August 2016, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  76. The Impact of Routine Angiographic Follow-Up in a Population of Patients Undergoing Percutaneous Coronary Intervention Within the Left Main Coronary Artery

    Article • Angiology, July 2016, SAGE Publications

    Dr Radoslaw Lenarczyk

  77. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population

    Article • Heart Rhythm, May 2016, Elsevier

    Dr Radoslaw Lenarczyk

  78. In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study

    Article • PLOS One, April 2016, PLOS

    Dr Radoslaw Lenarczyk

  79. Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)

    Article • Polish Archives of Internal Medicine, March 2016, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

    Dr Radoslaw Lenarczyk

  80. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure

    Article • Herz, February 2016, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  81. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience

    Article • Kardiologia Polska, January 2016, Polskie Towarzystwo Kardiologiczne

    Dr Radoslaw Lenarczyk

  82. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey

    Article • EP Europace, January 2016, European Society of Cardiology

    Dr Radoslaw Lenarczyk, Kristina Haugaa

  83. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey

    Article • EP Europace, December 2015, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  84. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    Article • European Heart Journal, August 2015, European Society of Cardiology

    Professor Tchavdar N Shalganov, Prof HECTOR BUENO, Dr Radoslaw Lenarczyk, Professor Erkin Mirrakhimov, Dr Ayan Abdrakhmanov

  85. Liczba i wskaźniki objętości płytek krwi u chorych z wywołanym kontrastem ostrym uszkodzeniem nerek i zawałem serca leczonych inwazyjnie

    Article • Kardiologia Polska, July 2015, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  86. Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation

    Article • Journal of Cardiovascular Medicine, July 2015, Wolters Kluwer Health

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  87. Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?

    Article • Cardiology Journal, June 2015, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  88. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients

    Article • EP Europace, May 2015, European Society of Cardiology

    Dr Ewa Jędrzejczyk-Patej, Dr Radoslaw Lenarczyk

  89. Quality of Life in Cardiac Resynchronization Recipients: Association with Response and Impact on Outcome

    Article • Pacing and Clinical Electrophysiology, October 2014, Wiley

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  90. Naprzemienny blok prawej i lewej odnogi pęczka Hisa

    Article • Kardiologia Polska, October 2014, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  91. Skuteczność terapii resynchronizującej w leczeniu pacjentów ze schyłkową niewydolnością serca zależnych od leków inotropowych

    Article • Kardiologia Polska, September 2014, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  92. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

    Article • European Heart Journal, August 2014, European Society of Cardiology

    Professor Perry M Elliott, Dr Radoslaw Lenarczyk, Prof HECTOR BUENO

  93. Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy

    Article • Cardiology Journal, August 2014, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  94. Sleep-disordered breathing and echocardiographic measures of function and dyssynchrony

    Article • Journal of Cardiovascular Medicine, July 2014, Wolters Kluwer Health

    Dr Radoslaw Lenarczyk

  95. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm

    Article • Cardiology Journal, June 2014, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  96. Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy—incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial

    Article • Journal of Interventional Cardiac Electrophysiology, March 2014, Springer Science + Business Media

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  97. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities

    Article • European Journal of Preventive Cardiology, March 2014, SAGE Publications

    Dr Radoslaw Lenarczyk, Dr Jacek Kowalczyk

  98. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges

    Article • Kardiologia Polska, January 2014, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  99. The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function

    Article • Cardiology Journal, December 2013, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  100. Migotanie przedsionków u chorej z utajonym zespołem Wolffa-Parkinsona-White’a

    Article • Kardiologia Polska, November 2013, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  101. Is it important to monitor the percentage of cardiac resynchronization day by day?

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  102. The risk of contrast-induced nephropathy and its prognostic significance in patients with different glucose abnormalities and acute myocardial infarction treated invasively

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  103. Trying to predict the unpredictable:device-based daily monitored parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  104. Lack of improvement in quality of life after cardiac resynchronization therapy is a potent determinant of unfavorable outcomes independently from functional and echocardiographic response

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  105. Atrial fibrillation types predict the development of contrast-induced nephropathy in patients with acute myocardial infarction treated invasively

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  106. The incidence, clinical significance of depression and changes in its clinical course after a cardiac device implantation in patients with congestive heart failure

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  107. Upgrade of implantable cardioverter-defibrillator to Cardiac Resynchronization Therapy with Defibrillator (CRT-D). In which patients shall we expect?

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  108. Wielopunktowa stymulacja dwukomorowa w terapii resynchronizującej serce

    Article • In a Good Rhythm, June 2013, Index Copernicus

    Dr Radoslaw Lenarczyk

  109. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial

    Article • EP Europace, March 2013, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  110. Burza elektryczna w erze pacjentów z kardiowerterem-defibrylatorem

    Article • Kardiologia Polska, February 2013, VM Media SP. zo.o VM Group SK

    Dr Radoslaw Lenarczyk

  111. Pacemaker endocarditis – did we let the genie out of the bottle? Comment on "Implantation of an epicardial lead through mini-thoracotomy as an alternative for patients with lead-related endocarditis who require permanent pacing"

    Article • Polish Journal of Cardio-Thoracic Surgery, January 2013, Termedia Sp. z.o.o.

    Dr Radoslaw Lenarczyk

  112. Effect of Type of Atrial Fibrillation on Prognosis in Acute Myocardial Infarction Treated Invasively

    Article • The American Journal of Cardiology, June 2012, Elsevier

    Dr Radoslaw Lenarczyk

  113. Implantation Feasibility, Procedure-Related Adverse Events and Lead Performance During 1-Year Follow-Up in Patients Undergoing Triple-Site Cardiac Resynchronization Therapy: A Substudy of TRUST CRT Randomized Trial

    Article • Journal of Cardiovascular Electrophysiology, May 2012, Wiley

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  114. The risk of stroke in patients with acute myocardial infarction treated invasively

    Article • Coronary Artery Disease, January 2012, Wolters Kluwer Health

    Dr Radoslaw Lenarczyk

  115. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively

    Article • Cardiovascular Diabetology, January 2012, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  116. Effect of Cardiac Resynchronization on Gradient Reduction in Patients with Obstructive Hypertrophic Cardiomyopathy: Preliminary Study

    Article • Pacing and Clinical Electrophysiology, August 2011, Wiley

    Dr Radoslaw Lenarczyk

  117. The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI

    Article • Catheterization and Cardiovascular Interventions, May 2011, Wiley

    Dr Radoslaw Lenarczyk, Dr Ewa Jędrzejczyk-Patej

  118. The Incremental Value of Right Ventricular Indices for Predicting Response to Cardiac Resynchronization Therapy

    Article • Journal of the American Society of Echocardiography, February 2011, Elsevier

    Dr Radoslaw Lenarczyk

  119. Assessment of apical rocking: a new, integrative approach for selection of candidates for cardiac resynchronization therapy

    Article • European Journal of Echocardiography, July 2010, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  120. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators

    Article • Future Cardiology, May 2010, Future Medicine

    Dr Radoslaw Lenarczyk

  121. Effect of Anemia in High-Risk Groups of Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention

    Article • The American Journal of Cardiology, March 2010, Elsevier

    Dr Radoslaw Lenarczyk

  122. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm

    Article • Journal of Interventional Cardiac Electrophysiology, February 2010, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  123. Prognostic Significance of Hyperuricemia in Patients with Different Types of Renal Dysfunction and Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Dr Radoslaw Lenarczyk

  124. Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation

    Article • Journal of Cardiovascular Electrophysiology, June 2009, Wiley

    Dr Radoslaw Lenarczyk

  125. Effects of Cardiac Resynchronization Therapy on Heart Rate Turbulence

    Article • Pacing and Clinical Electrophysiology, March 2009, Wiley

    Dr Radoslaw Lenarczyk

  126. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: A preliminary study

    Article • International Journal of Cardiology, March 2009, Elsevier

    Dr Radoslaw Lenarczyk

  127. Premature Complexes, Atrial and Ventricular

    Article • January 2009, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  128. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy

    Article • EP Europace, November 2008, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  129. Evaluation of left ventricular systolic and diastolic function in patients with atrioventricular re-entrant tachycardia treated by radiofrequency current ablation

    Article • Acta Cardiologica, April 2008, Peeters Publishers

    Dr Radoslaw Lenarczyk

  130. Doppler predictors of inducibility of atrial fibrillation in patients with WPW syndrome and atrioventricular re-entrant tachycardia

    Article • Acta Cardiologica, November 2007, Peeters Publishers

    Dr Radoslaw Lenarczyk

  131. Sequence of electrical activation, atrial remodelling and atrial fibrillation in patients with nodal re-entrant tachycardia

    Article • Acta Cardiologica, November 2007, Peeters Publishers

    Dr Radoslaw Lenarczyk

  132. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study

    Article • EP Europace, July 2007, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  133. Resynchronization or Dyssynchronization?Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony

    Article • Journal of Cardiovascular Electrophysiology, May 2007, Wiley

    Dr Radoslaw Lenarczyk

  134. Triple site biventricular pacing in a patient with congestive heart failure and severe mechanical dyssynchrony

    Article • Journal of Interventional Cardiac Electrophysiology, April 2007, Springer Science + Business Media

    Dr Radoslaw Lenarczyk

  135. Different Types of Renal Dysfunction in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention

    Article • Journal of Interventional Cardiology, April 2007, Wiley

    Dr Radoslaw Lenarczyk

  136. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention

    Article • American Heart Journal, February 2007, Elsevier

    Dr Radoslaw Lenarczyk

  137. Influence of Reciprocating Tachycardia on the Development of Atrial Fibrillation in Patients with Preexcitation Syndrome

    Article • Pacing and Clinical Electrophysiology, January 2007, Wiley

    Dr Radoslaw Lenarczyk

  138. 172 Sleep apnea in patients with cardiac resynchronization therapy - what role plays an echocardiography: background, equal or just a helping hand?

    Article • European Journal of Echocardiography, December 2006, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  139. 394 The influence of cardiac resynchronization therapy on right ventricular systolic function in heart failure patients with right ventricular impairment

    Article • European Journal of Echocardiography, December 2006, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  140. Effect of Percutaneous Interventions within the Coronary Sinus on the Success Rate of the Implantations of Resynchronization Pacemakers

    Article • Pacing and Clinical Electrophysiology, October 2006, Wiley

    Dr Radoslaw Lenarczyk

  141. Coronary sinus stenting for the stabilization of left ventricular lead during resynchronization therapy

    Article • EP Europace, March 2006, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  142. A37-4 Surface ECG can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  143. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  144. P-089 Radiofrequency catheter ablation in patients with congenital heart disease

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  145. P-164 Trend of heart rate variability in patients treated with cardiac resynchronization therapy

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  146. P-043 The evaluation of paroxysmal atrial fibrillation using event holter loop recording

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  147. A05-2 Atrial pressures during reciprocating tachycardia as a risk factor for atrial fibrillation in WPW-patients

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  148. A24-2 Atrial conduction velocity is a marker of atriomyopathy progression in patients with atrial flutter

    Article • EP Europace, December 2003, European Society of Cardiology

    Dr Radoslaw Lenarczyk

  149. A37-4 Surface ecg can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia

    Article • EP Europace, December 2003, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  150. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy

    Article • EP Europace, December 2003, Oxford University Press (OUP)

    Dr Radoslaw Lenarczyk

  151. Electrophysiological Features of Orthodromic Atrioventricular Reentry Tachycardia in Patients with Wolff-Parkinson-White Syndrome and Atrial Fibrillation

    Article • Pacing and Clinical Electrophysiology, July 2003, Wiley

    Dr Radoslaw Lenarczyk

  152. P354 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy

    Article • European Heart Journal, March 2003, Elsevier

    Dr Radoslaw Lenarczyk